A 20-year retrospective review of surgically treated liposarcoma at the Cleveland Clinic.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 17375550.
- Also identified by DOI 10.3928/01477447-20070301-01.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The records of 63 patients surgically treated for liposarcoma at the Cleveland Clinic between 1975 and 1995 were examined. Both metastatic disease (Enneking stage IIl) and an abdominal location were found to be poor prognosticants for survival. Age, gender, or tumor size, setting, or grade did not have any prognostic significance. The 5-year disease-specific survival for extremity tumors was 92% (95% confidence interval [CI]; range: 84%-100%), while general 5-year survival for extremity tumors was 66% (95% Cl; range: 48%-85%).
Medical subject headings
- Liposarcoma
- Soft Tissue Neoplasms